Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication.
A journal author argues that the current health system puts too much emphasis on patient safety when our resources should instead be aimed at the programs and activities that will result in the greatest overall improvement in patient health.
Theodore E. Schall, PhD, MSW, MBE, Kaitlyn Jaffe, PhD, and Jacob D. Moses, PhD
Clinicians should know how randomized controlled trials can and cannot contribute to advancing health equity for transgender and gender diverse people.
AMA J Ethics. 2024;26(9):E684-689. doi:
10.1001/amajethics.2024.684.